Skip to main content

Month: May 2023

MetaWorks to Launch New Blockchain Based NFT Ticketing Solution at Breathe Convention in Las Vegas

New NFT Ticketing Platform Will Eliminate Scalping and Drive Secondary Market Sales for the Benefit of Artists, Venue Promoters and the Fans Fairfield, CA., May 16, 2023 (GLOBE NEWSWIRE) — MetaWorks Platforms, Inc. (“MetaWorks” or the “Company”), (CSE: MWRK and OTCQB: MWRK), an award-winning Web3 company that owns and operates blockchain platforms in the entertainment technology space, is pleased to announce that it will launch version 1.0 of its Blockchain based NFT event ticketing system and decentralized wallet product, WalletFX, at the Breathe Convention in Las Vegas from September 13 to September 15, 2023. MetaWorks Platforms President Scott Gallagher commented, “Ticketing is one of those rare areas where the core problems can be solved by properly applied technology. Blockchain, NFTs and Smart Contracts done right will be...

Continue reading

EIMSKIP: Results for Q1 2023

HIGHLIGHTS OF QUARTER ONE Overall good results, driven by strong performance of the Container liner services, while results in International forwarding decreased, as expected, with market conditions that have significantly changed as the global shipping market has normalized.Sharp decline in global freight rates resulting in a decrease in both revenue and cost YoY, mainly through purchase of third-party services. Overall moderate growth in liner volumes compared to same quarter last year or an increase of 5.3%. Import to Iceland remained on a strong level and export from Iceland and Faroe Islands benefitted from strong pelagic seasons while export of farmed salmon and industrial cargo from Iceland was lower than expected. Trans-Atlantic volume grew by 9.6% and rates decreased from Q4 2022 levels and were on a similar level as in Q1...

Continue reading

Delta Drone: Sale of Delta Drone Human Tech and its operating subsidiaries

Sale of Delta Drone Human Techand its operating subsidiaries Dardilly, 16 May 2023 at 6 p.m. In accordance with what was previously announced (see 2022 annual financial report and press release of April 17, 2023), Delta Drone announces the completion of the sale of 100% of the “private security” division, composed of Delta Drone Human Tech and its three operating subsidiaries acting under the ATM brand. The “private security” division was sold to its founding Directors, in a very friendly context and with the desire to pursue common commercial developments, in line with the strategy of “dronification“ of the security sector initiated for several years. In addition to the induced cash injection, the transaction will have significant consequences for Delta Drone’s future profile, mainly:Delta Drone Human...

Continue reading

Rubicon Benefits Joins World Insurance Associates LLC

ISELIN, NJ, May 16, 2023 (GLOBE NEWSWIRE) — World Insurance Associates LLC (“World”), a Top 50 Insurance Brokerage, announced today that it acquired the business of Rubicon Benefits LLC (“Rubicon Benefits”) of Melville, NY on April 1, 2023. Terms of the transaction were not disclosed. Rubicon Benefits was founded in 2000. Today they provide employee benefits to businesses in the New York metropolitan area, as well as across the country. “Rubicon Benefits strives to become a strategic partner with employers, leveraging successful strategies in plan design so our clients can attract and retain top talent, and save money without reducing benefits,” says Adam Rosenfeld, President, Rubicon Benefits. “We look forward to continuing this approach as part of World.” “It’s great to welcome Rubicon Benefits to the World family,” says Rich...

Continue reading

Ryvu Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update

Updated Clinical Data from the Ongoing Phase Ib Dose-Escalation Study of RVU120 in Patients with AML or High-Risk MDS and Preclinical Data from the Combination Study of RVU120 and Ruxolitinib in Myeloproliferative Neoplasms to be Presented at the upcoming 2023 EHA Congress; Anticipated commencement of three Ryvu-sponsored Phase II trials of RVU120 in solid tumors and AML/HR-MDS in 2H 2023; Updated in vivo data from the MTA-cooperative PRMT5 inhibitor program presented at AACR Annual Meeting 2023;KRAKOW, Poland, May 16, 2023 (GLOBE NEWSWIRE) — Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address emerging targets in oncology, today reported financial results for the first quarter ended March 31, 2023, and provided a corporate update. “We...

Continue reading

eureKING, the first European SPAC in healthcare dedicated to biomanufacturing, announces its intention to combine with Skyepharma to build a new European bio-CDMO leader

eureKING png eureKINGSkyepharma SkyepharmaSkyepharma, a France-based CDMO with over 20 years of innovation and development expertise, is a renowned player in the global biopharma and consumer health industries. The company’s unique offer in the biomanufacturing process spans all stages of clinical development, marketing and product lifecycle.The proposed transaction would represent the first cornerstone of eureKING’s project to pursue bolt-on acquisitions to add innovative companies from the fast-growing biotherapies segments to its platform to create a bio-CDMO leader.eureKING has a clear and identified roadmap to bolster Skyepharma’s technology platform to consolidate the highly fragmented European market in biomanufacturing capacity, such as state–of–the–art facilities to manufacture cell and gene therapies...

Continue reading

VINCI Autoroutes and VINCI Airports traffic in April 2023

  Nanterre, 16 May 2023 VINCI Autoroutes and VINCI Airports traffic in April 2023  I-      Change in VINCI Autoroutes’ intercity networks traffic   April YTD at the end of April (4 months)  % change 2023/2022 % change 2023/2022VINCI Autoroutes +4.4% +2.3%Light vehicles +5.7% +3.0%Heavy vehicles −3.0% −1.1%Traffic on VINCI Autoroutes’ network continued to improve in April with a favorable effect associated with the positioning of the bank holidays for light vehicle. The decline in heavy vehicle traffic is attributable to the fact that there was one fewer working day in April 2023 than in April 2022. Overall, during the first four months of the year, all vehicles combined, traffic remained on a positive trajectory. II-      Change in VINCI Airports passenger traffic1  April YTD...

Continue reading

Euronext publishes Q1 2023 results

Contacts Media Contact Investor RelationsAmsterdam +31 20 721 4133 Brussels +31 20 721 4133 +33 1 70 48 24 27Dublin +33 1 70 48 24 45 Lisbon +351 210 600 614  Milan +39 02 72 42 62 12 Oslo +47 41 69 59 10  Paris +33 1 70 48 24 45      Euronext publishes Q1 2023 results Solid quarter driven by non-volume business organic growth Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 16 May 2023 – Euronext, the leading pan-European market infrastructure, today publishes its results for the first quarter of 2023.Q1 2023 revenue and income was €372.3 million (-5.9% compared to Q1 2022):Strong performance of non-volume related business:Technology Solutions reported €27.6 million of revenue (+19.4%1) thanks to the internalisation of colocation services following the migration of the Core Data Centre to Italy. Advanced...

Continue reading

Mycorrhiza-based Biofertilizers Market Size More Than Doubles to Touch USD 1.63 Billion With the CAGR of 14.15% by 2029 | BlueWeave Consulting

The Asia-Pacific region holds the highest market share for mycorrhizae-based biofertilizers due to the rising consumer preference for organic food consumption and the numerous government initiatives and reforms implemented by major Asian countries, including India, China, and Indonesia. Furthermore, key market players are investing in establishing manufacturing facilities in these countries to cater to the increasing demand for biofertilizers, which is expected to boost market growth. Similarly, North America dominated the global market, with a significant market share, owing to increased government interventions in promoting organic farming practices and early adoption of advanced and innovative products in countries such as the US and Canada. New Delhi, May 16, 2023 (GLOBE NEWSWIRE) — Global mycorrhiza-based biofertilizers market...

Continue reading

Vaisala Oyj: SHARE REPURCHASE 16.5.2023

VAISALA CORPORATION STOCK EXCHANGE RELEASE, 16.5.2023          VAISALA CORPORATION: SHARE REPURCHASE 16.5.2023       In the Helsinki Stock Exchange         Trade date           16.5.2023  Bourse trade         Buy  Share                  VAIAS  Amount             2 000 SharesAverage price/ share    42,0898 EURTotal cost            84 179,60 EUR          Vaisala Corporation now holds a total of 150 300 sharesincluding the shares repurchased on 16.5.2023            On behalf of Vaisala Corporation         Nordea Bank Oyj         Janne Sarvikivi           Sami Huttunen                 Additional information     Paula Liimatta    tel +358 9 8949 2020,     ir@vaisala.com              www.vaisala.com         ​​​​​Vaisala is a global leader...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.